Kimberly Gentile

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Gentile:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. SVP, Clinical Operations Common Shares 99,557 $988,601 $9.93 05 Jan 2026 Direct
Biohaven Ltd. SVP, Clinical Operations Stock Options (Right to buy) 91,000 05 Jan 2025 Direct
Biohaven Ltd. SVP, Clinical Operations Restricted Share Unit Award 7,500 05 Jan 2026 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Common Shares 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. SVP, Clinical Operations Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Kimberly Gentile

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BHVN Biohaven Ltd. 05 Jan 2026 3 -$19,423 4 SVP, Clinical Operations 07 Jan 2026, 21:34
BHVN Biohaven Ltd. 05 Jan 2025 5 -$75,580 4 SVP, Clinical Operations 07 Jan 2025, 20:50
BHVN Biohaven Ltd. 02 Jan 2024 1 $0 4 SVP, Clinical Operations 04 Jan 2024, 20:07
BHVN Biohaven Ltd. 02 Nov 2023 1 $0 4 SVP, Clinical Operations 06 Nov 2023, 20:32
BHVN Biohaven Ltd. 03 Oct 2022 42 +$18,716 4 SVP, Clinical Operations 05 Oct 2022, 17:42
BHVN Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 16 -$1,730,470 4 SVP, Clinical Operations 03 Oct 2022, 20:20
BHVN Biohaven Ltd. 28 Sep 2022 0 $0 3 SVP, Clinical Operations 30 Sep 2022, 16:31
BHVN Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 5 -$222,948 4 SVP, Clinical Operations 07 Jan 2022, 20:17
BHVN Biohaven Pharmaceutical Holding Co Ltd. 25 Nov 2021 3 -$200,826 4 SVP, Clinical Operations 26 Nov 2021, 15:30